Cymoxanil and its associated end-use products : final decision.: H113-28/2021-9E-PDF
"This document presents the final re-evaluation decision for the re-evaluation of cymoxanil, including the required amendments (risk mitigation measures) to protect human health and the environment, as well as label amendments required to bring labels to current standards. All products containing cymoxanil that are registered in Canada are subject to this re-evaluation decision"--Page 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.906199&sl=0
| Department/Agency |
|
|---|---|
| Title | Cymoxanil and its associated end-use products : final decision. |
| Series title |
|
| Publication type | Monograph - View Master Record |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (10 pages). |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: